AI could be the key to catching Type 1 diabetes much earlier

IBM’s latest project could help identify patients at risk and help chart a course for tracking the condition.

Will AI lead to a quicker diagnosis of diabetes, a condition often called the silent killer? IBM researchers are hoping so. They recently announced an AI-powered screening tool that could potentially identify Type 1 diabetes antibodies in people’s blood.

For the millions of people who live with Type 1 diabetes globally, everyday reality involves significant self monitoring. Without that supervision, the pancreas fails to produce enough insulin, which is used to move energy-providing blood sugar to the body’s cells. From daily insulin injections to ensuring that blood glucose levels are in check with nutrition and exercise plans, it’s a condition that requires patients to stay highly vigilant about their health.